Skip to main content
Novartis
language-selector-globe
Novartis weltweit
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • Über uns 
      • Unser Unternehmen 
        • Unser Geschäftsmodell 
        • Unsere Geschäftsleitung 
        • Standorte in Deutschland 
      • Das macht uns aus 
      • Digitale Innovation 
      • Unser Engagement 
        • Transparenz von Leistung an Fachkreisangehörige 
        • Transparenz von Zuwendungen an Patient*innengruppen 
        • Umsetzung des deutschen Lieferkettensorgfaltspflichtengesetzes (LkSG) 
        • Implementation of the German Supply Chain Due Diligence Act (SCDDA) 
      Mutter und Tochter im Kinderzimmer
      Über uns
    • Arzneimittel und Forschung 
      • Produktportfolio 
        • Arzneimittel der Novartis Pharma A-Z 
        • Arzneimittel der Novartis Pharma A-Z (DocCheck) 
      • Informationen für Fachkreisangehörige 
      • Klinische Forschung 
      • Forschungsstandort Deutschland 
      • Fokus auf Patient*innen und Wissenschaft 
      • Förderung von Wissenschaft & Forschung 
      Wissenschaftler im Labor
      Arzneimittel und Forschung
    • Patient*innen 
      • Das Novartis Versprechen für Patient*innen und Angehörige 
      • Krankheitsgebiete und Technologieplattformen 
        • Immunologie 
          • Akne inversa/ Hidradenitis suppurativa 
          • Chronische spontane Urtikaria 
          • Morbus Bechterew / Axiale Spondyloarthritis (axSpA) 
          • Schuppenflechte/ Plaque-Psoriasis 
        • Kardiologie 
          • Chronische Herzinsuffizienz 
          • Erkrankungen der Niere 
            • IgA- Nephropathie 
            • Das atypische hämolytisch-urämische Syndrom 
            • Immunkomplex-vermittelte membranoproliferative Glomerulonephritis 
            • C3- Glomerulopathie 
          • Hypercholesterinämie 
        • Neurologie 
          • Migräne 
          • Multiple Sklerose 
          • Spinale Muskelatrophie (SMA) 
        • Onkologie 
          • Hämatologie 
            • Polycythaemia Vera (PV) 
            • Myelofibrose (MF) 
            • Die paroxysmale nächtliche Hämoglobinurie 
          • Solide Tumore 
            • Brustkrebs 
            • Neuroendokrine Tumore (NET) 
            • Prostatakarzinom 
        • Atemwegserkrankungen 
        • Augenheilkunde 
        • Radioligandentherapie 
      • Unser Engagement für ein besseres Leben mit Erkrankungen 
        • Unser Engagement für Patient*innensicherheit 
          • Neben- und Wechselwirkungen einfach erklärt 
          • Der Medikationsplan 
      • Patientenperspektive in der klinischen Forschung 
      • Digitale Gebrauchsinformationen von Novartis 
      Glückliche Familie
      Patient*innen
    • Karriere 
      • Offene Stellen 
      • Ihr Einstieg bei Novartis 
        • Berufseinsteigende und Berufserfahrene 
        • Traineeprogramme für Hochschulabsolvent*innen 
        • Schüler*innen und Student*innen 
          • Duales Studium bei Novartis 
            • Duales Studium bei Novartis - BWL-Gesundheitsmanagement (B.A.) 
            • Duales Studium bei Novartis - BWL-Industrie (B.A.) 
          • Praktikum bei Novartis 
      • Darum Novartis 
        • Vergütung und Benefits 
        • Personalentwicklung 
        • Top-Employer 
        • Persönliche Einblicke 
        • Diversity, Equity & Inclusion 
      • So arbeiten wir 
      • Lernen und Weiterbildung 
      • Gesundheit und Wohlbefinden 
      • FAQ 
      Drei Kollegen im Gespräch
      Karriere
    • Medien 
      • Pressemitteilungen 
      • Aktuelles 
      • Geschichten 
      • In den Nachrichten 
      • Mediathek 
      • Medienkontakte 
      A photo of people in a meeting hall
      Medien
    • Novartis Pavillon 
    • Live Magazine 
    • SpeakUp 
    • Kontakt 
      Personen an einem Besprechungstisch
      Kontakt
    Wissenschaftlerin im Labor
    Home
  1. Home
  2. Offene Stellen
  3. Offene Stellen
  • Sort by Sort ascending
  • Positionsbezeichnung Sort ascending
  • Seite
  • Standort
  • Division
  • Business
  • Funktionsbereich
  • Datum der Veröffentlichung
Positionsbezeichnung Sort ascending Seite Standort Division Business Funktionsbereich Datum der Veröffentlichung
RA CMC Submission Coordinator Hyderabad (Office) Indien Development Development Research & Development Feb 05, 2026
RA CMC Senior Submission Coordinator Hyderabad (Office) Indien Development Development Research & Development Feb 05, 2026
Study Director Community Lead Barcelona Gran Vía Spanien Development Development Research & Development Feb 05, 2026
Senior Expert - Medical Device Analytical Representative (m/f/d) Schaftenau Österreich Development Development Research & Development Feb 05, 2026
Central Monitor Dublin (NOCC) Irland Development Development Research & Development Feb 05, 2026
Lead Central Monitor Dublin (NOCC) Irland Development Development Research & Development Feb 05, 2026
Medical Science Liaison (MSL) ONC Heme Chicago IL - Remote Field Non-Sales (USA) USA US Marketing Research & Development Feb 05, 2026
Regional Head CRMA EU London (The Westworks) Vereinigtes Königreich Development Development Research & Development Feb 05, 2026
Senior Expert Science & Technology (Analytical Chemistry Oligonucleotides) Basel (City) Schweiz Development Development Research & Development Feb 04, 2026
Field Medical Lead Jakarta Indonesien International Development Research & Development Feb 04, 2026
Head of US Risk Management & Product Safety (Risk Evaluation and Mitigation Strategies-REMS) East Hanover USA Development Development Research & Development Feb 04, 2026
Associate Director Medical Writer Barcelona Gran Vía Spanien Development Development Research & Development Feb 04, 2026
Medical Scientific Liaison - Immunology New South Wales (NSW) Australien International Legal Research & Development Feb 04, 2026
Manager (Sr.) Novartis Office of Grants and Education (NOGE) - East Hanover, NJ / DWA Distant Employee - Distant Working Arrangement (DWA) (USA) USA US Marketing Research & Development Feb 04, 2026
Medical Advisor Hong Kong Hongkong International Development Research & Development Feb 04, 2026
Ontology Designer - Data42 Hyderabad (Office) Indien Biomedical Research Research Research & Development Feb 04, 2026
Senior Expert Science & Technology I - Material Science Shanghai (Shanghai) China Development Development Research & Development Feb 04, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Medical Science Liaison (MSL) Onc Prostate Radioligand Therapies South Texas Remote Field Non-Sales (USA) USA US Marketing Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Central Monitor Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Director, Technology & Platforms Barcelona Gran Vía Spanien Development Development Research & Development Feb 03, 2026
Associate Director, Regulatory Affairs CMC Schaftenau Österreich Development Development Research & Development Feb 03, 2026
Director, Portfolio Scientific Communications London (The Westworks) Vereinigtes Königreich International Development Research & Development Feb 03, 2026
Senior Manager, Regulatory Affairs CMC Schaftenau Österreich Development Development Research & Development Feb 03, 2026
Manager, Regulatory Affairs CMC Schaftenau Österreich Development Development Research & Development Feb 03, 2026
Associate Clinical Development Director London (The Westworks) Vereinigtes Königreich Development Development Research & Development Feb 03, 2026
Clinical Development Medical Director (CDMD) Neuroscience London (The Westworks) Vereinigtes Königreich Development Development Research & Development Feb 03, 2026
Senior Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate or Manager, PHAD Japan Toranomon (NPKK Head Office) Japan Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Associate Expert Science & Technology Hyderabad (Office) Indien Development Development Research & Development Feb 03, 2026
Medical Science Liaison -BC Guangzhou (Guangdong Province) China International Development Research & Development Feb 02, 2026
Medical Science Liaison -BC Changsha (Hunan Province) China International Development Research & Development Feb 02, 2026
Medical Science Liaison-CSU Guangzhou (Guangdong Province) China International Development Research & Development Feb 02, 2026
Medical Science Liaison -BC Hefei (Anhui Province) China International Development Research & Development Feb 02, 2026
Medical Science Liaison -Hema Tianjin (Tianjin) China International Development Research & Development Feb 02, 2026
Medical Science Liaison -BC Tianjin (Tianjin) China International Development Research & Development Feb 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development Feb 02, 2026
Medical Safety Processes and Projects Manager Hyderabad (Office) Indien Development Development Research & Development Feb 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development Feb 02, 2026
RLT Medical Launch Liaison (RLT-MLL) Nanjing (Jiangsu Province) China International Development Research & Development Feb 02, 2026
Scientist in Drug Product Development, Senior Expert Science & Technology(m/f/d) Schaftenau Österreich Development Development Research & Development Feb 02, 2026

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • › Next page
No matching countries found
Suchen

Novartis Deutschland

Über Novartis
  • Über uns
  • Patient*innen
  • Medien
  • Karriere
  • Kontakt
Medien
  • Novartis Aktuell
  • Geschichten
  • Medienkontakte
Produktportfolio
  • Arzneimittel der Novartis
Weitere Novartis Webseiten
  • Fachkreiseportal
  • Infos zu klinischen Studien
Footer Bottom
© 2026 Novartis AG
  • Meldung von Nebenwirkungen
  • Nutzungsbedingungen
  • Datenschutzerklärung
  • Nutzung von Cookies auf Websites von Novartis
  • Impressum
  • Cookie-Einstellungen
  • Seitenverzeichnis
  • Barrierefreiheit im Web
Novartis Webseiten
Diese Seite richtet sich an Personen in Deutschland.